Form 4: GE HealthCare Director Tomislav Mihaljevic Awarded Restricted Stock Units

GE HealthCare Technologies Inc. Director Tomislav Mihaljevic was awarded 3,092 restricted stock units, increasing his beneficial ownership to 9,116 shares.

Summary

• Director Tomislav Mihaljevic of GE HealthCare Technologies Inc. received an award of 3,092 restricted stock units (RSUs) on May 28, 2025.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock.
• The awarded RSUs will vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Following this transaction, Mr. Mihaljevic beneficially owns a total of 9,116 shares of GE HealthCare common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The filing reports a standard equity award to a director, which is a common practice for aligning management and director interests with shareholders. It does not contain any negative or significantly positive operational or financial news, thus indicating a neutral to slightly positive sentiment due to alignment of interests.

Positives

• The award of restricted stock units to a director aligns their long-term interests with those of the company's shareholders.
• The vesting schedule encourages continued commitment and performance from the director.

Future Outlook

The restricted stock units are subject to a future vesting schedule, with 100% vesting on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026. Settlement of vested units may be deferred by the reporting person according to the company's Non-Employee Director Compensation and Benefits Plan.

Industry Context

The award of restricted stock units to a director is a common and standard practice for publicly traded companies across various industries, including healthcare technology. This form of equity compensation is widely used to incentivize and align the interests of directors with the long-term performance and shareholder value of the company.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a component of non-employee director compensation is a prevalent practice among large public companies, including those in the medical technology and healthcare equipment sectors.
• Companies such as Siemens Healthineers, Philips, and Medtronic commonly utilize equity-based compensation to align their directors' interests with long-term shareholder value.
• The specific number of units awarded is typically benchmarked against compensation data for peer group companies to ensure competitive and appropriate incentivization for board members.

Corporate Governance

Related Party Transactions

• The award of restricted stock units to Director Tomislav Mihaljevic constitutes a transaction with a related party (a director), which is a standard component of director compensation and is disclosed as required by SEC regulations.

Stakeholder Impact

• Shareholders: The award of equity to a director further aligns their financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Vesting of the 3,092 restricted stock units will occur on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Settlement of vested restricted stock units may be deferred by the reporting person in accordance with the company's Non-Employee Director Compensation and Benefits Plan.

Key Dates

Keywords

GE HealthCare, GEHC, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Stock Award, Tomislav Mihaljevic